Sort
10,766 grants matching “checkpoint inhibitor”
The integrated stress response and the microenvironment in melanoma progression
$406,333Constantinos Koumenis · University Of Pennsylvania · R01 · FY2023 · CA
Kinetochore Structure and Function
$406,296Timothy Yen · Research Inst Of Fox Chase Can Ctr · R01 · FY2007 · GM
Metabolic reprograming of fatty acid beta-oxidation to improve cancer immunotherapy
$406,274Xiang-Yang Wang · Virginia Commonwealth University · R01 · FY2022 · CA
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)
$406,245Jing Zhang · University Of Wisconsin-Madison · R01 · FY2025 · CA
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)
$406,245Jing Zhang · University Of Wisconsin-Madison · R01 · FY2023 · CA
Targeting EZH2 in CARM1-expressing epithelial ovarian cancer
$406,125Rugang Zhang · Wistar Institute · R01 · FY2017 · CA
Targeting EZH2 in CARM1-expressing epithelial ovarian cancer
$406,125Rugang Zhang · Wistar Institute · R01 · FY2020 · CA
Targeting EZH2 in CARM1-expressing epithelial ovarian cancer
$406,125Rugang Zhang · Wistar Institute · R01 · FY2018 · CA
Mechanisms of natural killer cell resistance of treatment-persistent residual tumor cells in hematologic malignancies
$406,038Constantine S. Mitsiades · Dana-Farber Cancer Inst · R01 · FY2023 · CA
ST8Sia6 expression on tumors inhibits the immune response
$406,002Virginia Smith Shapiro · Mayo Clinic Rochester · R01 · FY2020 · CA
Targeting PLK1 in RAS mutant chronic myelomonocytic leukemia
$405,775Mrinal Shiv Patnaik · Mayo Clinic Rochester · R01 · FY2024 · CA
Identification of serum protein biomarkers by profiling N-glycoproteomes of patient-derived xenografts of clear cell renal cell carcinoma
$405,619James D Brooks · Stanford University · R21 · FY2021 · CA
Elucidating the Roles of RNA m6A readers Y1 and Y2 in radiation-induced immunity and immunotherapy
$405,225Ralph R Weichselbaum · University Of Chicago · R01 · FY2025 · CA
Individualized in situ vaccination by radiation and immunotherapy
$405,106Sandra Demaria · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · CA
Discoidin Domain Receptor Tyrosine Kinase 2 in bladder cancer progression
$405,059Dan Theodorescu · Cedars-Sinai Medical Center · R01 · FY2022 · CA
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells
$405,031Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Endocytic Control of Autophagosome Formation in Lupus T cells
$405,000Andras Perl · Upstate Medical University · R01 · FY2017 · AI
Endocytic Control of Autophagosome Formation in Lupus T cells
$405,000Andras Perl · Upstate Medical University · R01 · FY2020 · AI
Endocytic Control of Autophagosome Formation in Lupus T cells
$405,000Andras Perl · Upstate Medical University · R01 · FY2018 · AI
Endocytic Control of Autophagosome Formation in Lupus T cells
$405,000Andras Perl · Upstate Medical University · R01 · FY2019 · AI
Cyclic Immunofluorescent Imaging in Live Cells
$404,994Hannah Marie Peterson · Aperture Bio, Inc. · R43 · FY2025 · CA
Metabolic reprograming of fatty acid beta-oxidation to improve cancer immunotherapy
$404,924Xiang-Yang Wang · Virginia Commonwealth University · R01 · FY2023 · CA
Reprogramming the Tumor Microenvironment in Ovarian Cancer
$404,843David D Schlaepfer · University Of California, San Diego · R01 · FY2023 · CA
Reprogramming the Tumor Microenvironment in Ovarian Cancer
$404,843David D Schlaepfer · University Of California, San Diego · R01 · FY2022 · CA
Role of microbial-modulated bile acid receptor signaling in breast cancer
$404,685Liza Makowski Hayes · University Of Tennessee Health Sci Ctr · R01 · FY2021 · CA